Please support An Act Establishing A Commission to Study Pancreatic Cancer. H.3746 was sponsored by Representative Elizabeth Poirier at my request and is co-sponsored by 45 other legislators.
The full text of the H.3746 may be read at https://malegislature.gov/Bill…
H.3746 was based upon a recent Budget Amendment by Rep. Colleen Garry that was successfully adopted to form a special commission on Ovarian Cancer (Outside Section 154). Rep. Garry is one of the co-sponsors of H.3746.
As many of you know my father, Norman Cordeiro of Dartmouth, died of pancreatic cancer on March 30, 2014 after a 6-month battle with the disease. Since then I have become a volunteer for the Boston Affiliate of the Pancreatic Cancer Action Network (PanCAN) as well as the American Cancer Society Cancer Action Network.
To put things into a political context, my dad fell ill with pancreatic cancer on the night of our Massachusetts Republican State Committee meeting in September 2013 and was rushed to the hospital for the final time on the day after our MassGOP 2014 State Convention. Of course, pancreatic cancer – like any cancer – transcends politics and ideology. However, we now have an opportunity through an act of the legislature, signed into law by Governor Charlie Baker, to make a real difference in the fight against pancreatic cancer!
As PanCAN Boston says we can WAGE HOPE!
Here are some statistics from PanCAN:
PANCREATIC CANCER IS ONE OF THE DEADLIEST CANCERS
• Pancreatic cancer is the 4th leading cause of cancer-related death for both men and women in the United States, and it is the 11th most commonly diagnosed cancer in men and the 8th in women.
• It is estimated that in 2015, 48,960 Americans will be diagnosed with pancreatic cancer, and 40,560 will die from the disease. Seventy-two percent of patients will die within the first year of diagnosis.
• Pancreatic cancer is the only major cancer with a 5-year relative survival rate in the single digits, at just 7 percent.
• African-Americans have the highest incidence rate of pancreatic cancer, between 31 percent and 65 percent higher than the incidence rates for other racial/ethnic groups.
• While overall cancer incidence and death rates are declining, the incidence and death rates for pancreatic cancer are increasing. Pancreatic cancer is projected to move past breast and colorectal cancer to become the 2nd leading cause of cancer-related death in the United States around 2020.
The co-sponsors of H.3746, An Act Establishing A Commission to Study Pancreatic Cancer are as follows:
Petitioners: Elizabeth A. Poirier, James Arciero, Mark J. Cusack, Josh S. Cutler, Viriato M. deMacedo, Shawn Dooley, Peter J. Durant, Ryan C. Fattman, Kimberly N. Ferguson, John V. Fernandes, Carole A. Fiola, Paul K. Frost, Colleen M. Garry, Carmine L. Gentile, Susan Williams Gifford, Patricia A. Haddad, Robert L. Hedlund, Bradford R. Hill, Steven S. Howitt, Randy Hunt, Bradley H. Jones, Jr., Hannah Kane, Kay Khan, Robert M. Koczera, Kevin J. Kuros, Marc T. Lombardo, Joan B. Lovely, Christopher M. Markey, Joseph D. McKenna, Paul McMurtry, Mark C. Montigny, David K. Muradian, Jr., Mathew Muratore, Keiko M. Orrall, Angelo J. Puppolo, Jr., Michael J. Rodrigues, Richard J. Ross, Alan Silvia, Todd M. Smola, William M. Straus, Bruce E. Tarr, David T. Vieira, RoseLee Vincent, Chris Walsh, Timothy R. Whelan, Donald H. Wong, Brock N. Cordeiro